The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Completed · Phase 4 · Has a placebo group

Conditions studied: Ptosis, Eyelid, Conjunctiva Inflamed, Eye Manifestations

In brief

The purpose of the research is to see if Upneeq ( oxymetazoline 0.1% ophthalmic solution) has an effect on eyelid position, eye redness, or patient-perceived appearance of the eyes.

Key facts

Study ID
NCT04831047
Run by
University of Miami
People needed
114
Starts
2021-06-08
Expected to finish
2022-04-01
Last updated by the study team
2023-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.